NLS Pharmaceutics announced plans to showcase its global strategic R&D progress and platform, as well as its product candidate and pipeline goals for 2023, with a focus on rare and complex CNS disorders with unmet medical needs. NLS will webcast its upcoming virtual R&D Day event on the Investors section of the Company’s website, www.nlspharma.com, on January 31, 2023, at 10:00 am EST.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on NLSP:
- NLS Pharmaceutics announces patent grant for Mazindol
- NLS Pharmaceutics CEO says proprietary position on Quilience ‘is strong’
- NLS Pharmaceutics announces Israeli patent grant for Mazindol
- NLS Pharmaceutics closes initial tranche of $10M purchase agreement
- NLS Pharmaceutics upgraded to Buy from Hold at Maxim
